Literature DB >> 2480587

Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.

E Harboe1, C Larsen, M Johansen, H P Olesen.   

Abstract

The bioavailability of naproxen after oral administration of aqueous solutions of various dextran-naproxen ester prodrugs in pigs was determined. The dextran prodrugs employed ranged in molecular weight from 10,000 to 500,000. As calculated relative to an equivalent oral dose of parent naproxen, the absorption fractions of all the derivatives were close to 100%. Only small interindividual variation of naproxen bioavailability was observed. The naproxen plasma profiles for all the administered prodrugs exhibited a characteristic lag time of naproxen appearance in the blood (2-3 hr). Compared to administration of the prodrugs alone, coadministration of excess of the parent dextran further delayed the absorption of naproxen from the GI tract. The results of the present study demonstrate the potential of dextran prodrugs for colon site-specific delivery of drugs containing a carboxylic acid functional group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480587     DOI: 10.1023/a:1015981126732

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Distribution studies of salicylazosulfapyridine and its metabolites.

Authors:  M A Peppercorn; P Goldman
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

Review 2.  Topical mucosal adhesive dosage forms.

Authors:  T Nagai
Journal:  Med Res Rev       Date:  1986 Apr-Jun       Impact factor: 12.944

3.  Will there be a next generation of sulfasalazine?

Authors:  P Goldman
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

4.  Naproxen-metabolism, excretion and comparative pharmacokinetics.

Authors:  R Runkel; E Forchielli; G Boost; M Chaplin; R Hill; H Sevelius; G Thompson; E Segre
Journal:  Scand J Rheumatol Suppl       Date:  1973

5.  A new approach to the oral administration of insulin and other peptide drugs.

Authors:  M Saffran; G S Kumar; C Savariar; J C Burnham; F Williams; D C Neckers
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

6.  Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.

Authors:  C P Willoughby; J K Aronson; H Agback; N O Bodin; S C Truelove
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

7.  A polymeric drug for treatment of inflammatory bowel disease.

Authors:  J P Brown; G V McGarraugh; T M Parkinson; R E Wingard; A B Onderdonk
Journal:  J Med Chem       Date:  1983-09       Impact factor: 7.446

8.  Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer.

Authors:  M A Longer; H S Ch'ng; J R Robinson
Journal:  J Pharm Sci       Date:  1985-04       Impact factor: 3.534

9.  An oral preparation to release drugs in the human colon.

Authors:  M J Dew; P J Hughes; M G Lee; B K Evans; J Rhodes
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

10.  Drug glycosides: potential prodrugs for colon-specific drug delivery.

Authors:  D R Friend; G W Chang
Journal:  J Med Chem       Date:  1985-01       Impact factor: 7.446

View more
  9 in total

Review 1.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

Review 2.  Colonic drug delivery: prodrug approach.

Authors:  V R Sinha; R Kumria
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

3.  Macromolecular prodrugs. XVI. Colon-targeted delivery--comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract.

Authors:  C Larsen; E Harboe; M Johansen; H P Olesen
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

4.  In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.

Authors:  C S Leopold; D R Friend
Journal:  J Pharmacokinet Biopharm       Date:  1995-08

5.  Inulin hydrogels as carriers for colonic drug targeting: I. Synthesis and characterization of methacrylated inulin and hydrogel formation.

Authors:  L Vervoort; G Van den Mooter; P Augustijns; R Busson; S Toppet; R Kinget
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

6.  'Click' synthesis of dextran macrostructures for combinatorial-designed self-assembled nanoparticles encapsulating diverse anticancer therapeutics.

Authors:  Sampath C Abeylath; Mansoor M Amiji
Journal:  Bioorg Med Chem       Date:  2011-09-17       Impact factor: 3.641

7.  Multiple oral administration of a ketoprofen-dextran ester prodrug in pigs: assessment of gastrointestinal bioavailability by deconvolution.

Authors:  F Larsen; B H Jensen; H P Olesen; C Larsen
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

8.  Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.

Authors:  Wooseong Kim; Yejin Yang; Dohoon Kim; Seongkeun Jeong; Jin-Wook Yoo; Jeong-Hyun Yoon; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2017-02-14       Impact factor: 4.162

9.  Synthesis of methylprednisolone loaded ibuprofen modified dextran based nanoparticles and their application for drug delivery in acute spinal cord injury.

Authors:  Lei Qi; Haiyan Jiang; Xiaohui Cui; Guiwen Liang; Ming Gao; Zhongwei Huang; Qinghua Xi
Journal:  Oncotarget       Date:  2017-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.